Compare Brigit Biofarmaka Teknologi Tbk. (OBAT) vs Jaya Swarasa Agung Tbk. (TAYS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Brigit Biofarmaka Teknologi Tbk. vs Jaya Swarasa Agung Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 166.01B, 324K 24h volume), while Jaya Swarasa Agung Tbk. trades at Rp50 (market cap 54.95B). The key difference: Brigit Biofarmaka Teknologi Tbk. is far larger — about 3× Jaya Swarasa Agung Tbk.'s market cap. Which is the better fit depends on your goals.
| OBAT | TAYS | |
|---|---|---|
Market Cap | 166.01B | 54.95B |
Volume | 324K | — |
Lot | 3.24K | — |
Turnover | 77.68M | — |
Average Price | 239.75 | — |
Value | 77.68M | — |
Indicative Equilibrium Price | 240 | — |
Indicative Equilibrium Volume | 1 | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →About Jaya Swarasa Agung Tbk.
PT Jaya Swarasa Agung Tbk (the Company) was established based on Notarial Deed No. 4 dated May 1, 1998 of Trinawati Mulia, S.H., in Jakarta and has received approval as a legal entity from the Minister of Justice and Human Rights of the Republic from Indonesia dated July 19, 1999 through its Decision Letter No.C-13163.01.01.TH.99. The Company started its commercial operation in 1998.
Read more on TAYS →
